- Companies
- Assort Health
Assort Health Revenue, Valuation, Funding & Investors
Assort Health is valued at $1.2B as of June 2026.
Last Assort Health valuation
$1.2B
Series C · Jun 2026
Last Assort Health funding round
$120M
Series C · Jun 2026
Assort Health revenue
$3M
Series B · Aug 2025
Key investors in Assort Health
Quiet Capital
First Round Capital
Chemistry
Lightspeed Venture Partners
Felicis
Tau Ventures
About Assort Health
Assort Health is a San Francisco-headquartered developer of voice AI agents for healthcare contact centers, automating scheduling, rescheduling, cancellations, refills, and triage tasks. Its platform connects with electronic health records like Epic and Cerner, supports over 20 languages, and adapts to specialties including dermatology and orthopedics, allowing clinics nationwide to handle high call volumes efficiently.
Founded
2023
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Revenue
$3M (Aug 2025)
Valuation
$1.2B (Jun 2026)
Assort Health Valuation
Assort Health is currently valued at $1.2B, based on its Series C in June 2026.
The $120M round was led by Menlo Ventures, with participation from Tau Ventures, First Round Capital, Felicis, Lightspeed Venture Partners, Joe Montana and 2 other investors.
Assort Health's valuation has grown 1.6x from $750M at its Series B in August 2025 to $1.2B in June 2026, across 2 priced rounds.
Assort Health valuation by funding round
Revenue multiple| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Jun 2026 | Series C | $1.2B | - |
| Aug 2025 | Series B | $750M | 250.0x |
Assort Health Revenue
Assort Health's latest recorded revenue is $3M, as of its Series B in August 2025.
Assort Health revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Aug 2025 | $3M | $750M | 250.0x | Series B |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Assort Health Funding History
Assort Health has raised a total of $222M across 4 funding rounds.
Assort Health's first fundraising round was a $4M seed round in March 2024. The most recent completed round was a $120M Series C in June 2026.
Assort Health funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jun 2026 | Series C | Menlo Ventures (lead); Tau Ventures; First Round Capital; Felicis; Lightspeed Venture Partners; Joe Montana; Chemistry; Quiet Capital | $120M | $1.2B | Assort Health secured $120 million in Series C funding led by Menlo Ventures on June 24, 2026, at a valuation of $1.2 billion. The round includes participation from Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital, bringing the company's total capital raised to over $222 million since its inception in November 2023. This investment accelerates Assort Health's mission to become the standard for healthcare organizations transforming the patient journey through agentic AI, specifically scaling its voice AI agent platform for managing patient phone calls. The company, founded to develop voice AI agents for the healthcare industry, has rapidly grown from a $3.5 million seed round in 2024 to a $22 million Series A in April 2025 and now a $120 million Series C, positioning itself as the most widely-used AI agents platform for the patient journey in healthcare. |
| Aug 2025 | Series B | Lightspeed Venture Partners (lead); First Round Capital; Liquid 2 Ventures; Felicis; Paul Ricci; Chemistry; Quiet Capital; A* | $76M | $750M | Assort Health develops AI voice agents and an agentic AI platform (Assort OS) that automate patient communications for specialty healthcare practices, handling tasks like appointment scheduling, cancellations, prescription renewals, care navigation, and inquiries across voice, text, and web channels. The company targets small and medium-sized practices in orthopedics, physical therapy, OB-GYN, dermatology, and dentistry, reducing call drop rates by 2.7x, call duration by 50%, and operational costs while serving over 140 clinics and facilitating millions of interactions. In August 2025, Assort Health raised approximately $50 million in an initial Series B tranche led by Lightspeed Venture Partners at a $750 million post-money valuation, with participation from A*, Chemistry, Felicis, First Round Capital, Liquid 2 Ventures, Paul Ricci, and Quiet Capital. This followed a $22 million Series A in April 2025 led by First Round Capital and Chemistry, and a $3.5 million seed in 2024, bringing total funding to around $75.5 million at that point. By early October 2025, the Series B expanded to $76 million (total funding $102 million), with Lightspeed's Galym Imanbayev joining the board and Paul Ricci as advisor; funds will expand workforce and platform development. At the time of the August 2025 raise, Assort Health reported annual recurring revenue (ARR) just over $3 million, with rapid growth noted by investors comparing it favorably to Uber and Roblox. The company, founded two years prior by former medical student Jon Wang and ex-Facebook engineer Jeff Liu, operates amid a wave of healthcare AI investments, including EliseAI's $250 million Series E at $2.2 billion and Hello Patient's $20 million Series A at $100 million. |
| Apr 2025 | Series A | Chemistry (lead); First Round Capital (lead); Four Acres Capital; Allison Pickens Ventures; Quiet Capital; Tau Ventures | $22M | - | Assort Health is an AI platform founded in 2023 by Jon Wang and Jeff Liu that manages specialty-specific patient phone calls using AI-powered voice agents. The company automates high-volume administrative tasks such as scheduling appointments, handling cancellations, and answering frequently asked questions across specialty care practices including orthopedics, physical therapy, OB-GYN, dermatology, and dentistry. On April 16, 2025, Assort Health announced the completion of a $22 million Series A funding round co-led by First Round Capital and Chemistry, with participation from existing investor Quiet Capital. The round brought the company's total capital raised to $26 million, joining earlier backers Four Acres, Tau Ventures, and angel investors including senior executives and founders from Athena Health, Astrana Health, Flatiron Health, Infinitus, Mammoth Biosciences, Mercury, PathAI, and Presto. The company demonstrated exceptional traction, with revenue growing 8x since Q4 2024 and handling millions of inbound calls on behalf of customers without human intervention. Patient satisfaction ratings averaged 4.6 out of 5 stars. By the time of its Series B announcement just four months later in August 2025, Assort Health had raised an additional $50 million (with some sources citing $76 million) at a $750 million valuation, reflecting rapid investor confidence in its approach to automating patient communication in healthcare. |
| Mar 2024 | Seed | Quiet Capital (lead); Strategic Waterfall Partners; Four Acres Capital; Aditya Khosla; Tau Ventures; Pioneer Fund | $4M | - | Assort Health is a San Francisco-based healthcare AI company specializing in specialty-specific agentic AI agents that manage patient communications and phone calls. The platform, Assort OS, handles a comprehensive range of patient needs including appointment scheduling, care navigation, prescription renewals, physician referrals, and lab test coordination across multiple channels including voice, text, and web. The company was founded in 2023 and has demonstrated exceptional early traction, processing millions of inbound calls and approximately 42 million patient interactions, with patients reporting an average satisfaction rating of 4.6 out of 5. By its Series A round in April 2025, the company had achieved 8x revenue growth since Q4 2024, attracting institutional backing from First Round Capital and Chemistry alongside existing investors. Assort Health subsequently closed a $76 million Series B round in October 2025 led by Lightspeed Venture Partners, bringing total funding to $102 million and positioning the company as a leader in AI-driven patient engagement solutions for healthcare organizations. |
Who has invested in Assort Health?
17 investors have backed Assort Health across its funding rounds, including Quiet Capital, First Round Capital, Chemistry, Lightspeed Venture Partners, Felicis and Tau Ventures.
Lead investors include Menlo Ventures, Lightspeed Venture Partners, Chemistry, First Round Capital and Quiet Capital.
Assort Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 4 | Lead | Mar 2024 | ||
| 3 | Lead | Apr 2025 | ||
| 3 | Lead | Apr 2025 | ||
| 2 | Participant | Aug 2025 | ||
| 2 | Participant | Mar 2024 | ||
| 2 | Lead | Aug 2025 | ||
| 2 | Participant | Mar 2024 | ||
| 1 | Participant | Jun 2026 | ||
| 1 | Lead | Jun 2026 | ||
| 1 | Participant | Aug 2025 | ||
| 1 | Participant | Mar 2024 | ||
| 1 | Participant | Aug 2025 | ||
| 1 | Participant | Apr 2025 | ||
This data is available for Pro users. Sign up to see all 17 Assort Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAssort Health Competitors
Assort Health competitors include listed companies like Guiyang Longmaster and Medley Inc., and private ones like Tala Health, Wheel, League and Cadence Solutions.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $1.2B | - | ||
| Private | - | - | $1.2B | - | ||
| Private | - | - | $1.2B | - | ||
| Private | $35M | - | $1.2B | - | ||
| Publicly listed | $44M | $5M | $482M | - | ||
| Publicly listed | $236M | $32M | $459M | 1.8x |
Assort Health Public Comps
Assort Health is still privately-owned, but its public comps include U.S. Physical Therapy, GoodRx, Teladoc, PHC Holdings, EverCommerce, Vitec Software, iFLYHealth, Indegene, Omnicell and HealthStream.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $781M | $110M | 2.5x | 2.3x | 17.5x | 18.9x | |||
| $797M | $173M | 1.8x | 1.8x | 8.1x | 5.5x | |||
| $2.5B | $124M | 0.6x | 0.6x | 11.3x | 5.0x | |||
| $2.3B | $320M | 1.0x | 1.0x | 7.2x | 6.5x | |||
| $589M | $128M | 3.0x | 2.9x | 13.7x | 9.5x | |||
| $371M | $151M | 3.7x | 3.5x | 9.1x | 9.0x | |||
| $136M | ($7M) | 7.7x | 6.2x | (150.8x) | (144172.5x) | |||
| $366M | $68M | 3.7x | 3.3x | 19.9x | 18.2x | |||
This data is available for Pro users. Sign up to see all Assort Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Assort Health
| When was Assort Health founded? | Assort Health was founded in 2023. |
| Where is Assort Health headquartered? | Assort Health is headquartered in San Francisco, CA, United States. |
| Is Assort Health publicly listed? | No, Assort Health is a private, VC-backed company. |
| What is Assort Health's valuation? | Assort Health was last valued at $1.2B in its Series C in June 2026. |
| How much funding has Assort Health raised? | Assort Health has raised $222M across 4 funding rounds. |
| What was Assort Health's last funding round? | Assort Health's last funding round was a $120M Series C in June 2026, led by Menlo Ventures. |
| Who are Assort Health's investors? | Assort Health's investors include Quiet Capital, First Round Capital, Chemistry, Felicis, Four Acres Capital, Lightspeed Venture Partners, Tau Ventures, Tau Ventures, Menlo Ventures, Liquid 2 Ventures and 7 others. |
| What is Assort Health's revenue? | Assort Health's latest recorded revenue is $3M (August 2025). |
| Which companies are comparable to Assort Health? | Companies comparable to Assort Health include Tala Health, Wheel, League, Cadence Solutions, Guiyang Longmaster and Medley Inc.. |
See companies similar to Assort Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




